1. Arlt, M. F., Herzog, T. J., Mutch, D. G., Gersell, D. J., Liu, H. & Goodfellow, P. J. (1996). Frequent deletions of chromosome 1p sequences of aggressive histologic subtype of endometrial cancer. Hum Mol Genet 5: 1017–1021.
2. Bardi, G., Pandis, N., Fenger, C., Kronborg, O., Bomme, L. & Heim, S. (1993). Deletion of 1p36 as primary chromosomal aberration in intestinal tumorigenesis. Cancer Res, 53: 1895–1898.
3. Bello, M. J., de Campos, J. M., Kusak, M. E., Vaquero, J., Sarasa, J. L., Pestana, A. & Rey, J. A. (1994). Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer, 9: 296–298.
4. Bieche, I., Champème, M. H. & Lidereau, R. (1994). A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res 54: 4274–4276.
5. Bodmer, J. L., Burns, K., Sneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schroter, M., Becker, K., Wilson, A., French, L. E., Browning, J. L., MacDonald, H. R. & Tschopp, J. (1997). Tramp, a novel apotosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity, 6: 79–88.